logo topimg
title

August 11, 2010
The European Medicines Agency (EMA) and the Food and Drug Administration of the United States of America (US FDA) continue to seek potential candidate companies for a joint GMP inspection pilot programme for manufacturers of medicinal products.

July 23, 2010
Meeting highlights are available from the Committee for Medicinal Products for Human Use (CHMP) 19-22 July 2010.

July 23, 2010
The European Medicines Agency concludes its review of modified-release oral opioids of the WHO level III scale for the management of pain.

July 22, 2010
The European Medicines Agency has issued an update on the ongoing benefit-risk review of Avandia, Avandamet and Avaglim.

July 22, 2010
The European Medicines Agency confirms the positive benefit-risk balance of Rotarix.

July 22, 2010
The European Medicines Agency confirms the positive benefit-risk balance of topical formulations of ketoprofen.

July 20, 2010
A new policy on communicating safety-related issues on medicines for human use has been published by the European Medicines Agency (EMA).


botimg
  Copyright © 2010 CanReg Inc. All Rights Reserved.